Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Trans. S. Klein. Boston, MA: American Botanical Council, 1998.

Newall CA, Anderson LA, Philpson JD. Herbal Medicine: A Guide for Healthcare Professionals. London, UK: The Pharmaceutical Press, 1996.

Martindale W. Martindale the Extra Pharmacopoeia. Pharmaceutical Press, 1999.

Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics. 2nd ed. New York, NY: John Wiley & Sons, 1996.

Ellenhorn MJ, et al. Ellenhorn's Medical Toxicology: Diagnoses and Treatment of Human Poisoning. 2nd ed. Baltimore, MD: Williams & Wilkins, 1997.

Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. 1st ed. Montvale, NJ: Medical Economics Company, Inc., 1998.

Brinker F. Herb Contraindications and Drug Interactions. 2nd ed. Sandy, OR: Eclectic Medical Publications, 1998.

Pittler MH, Ernst E. Horse-chestnut seed extract for chronic venous insufficiency. A criteria-based systematic review. Arch Dermatol 1998;134:1356-60. View abstract.

Greeske K, Pohlmann BK. Horse chestnut seed extract-an effective therapy principle in general practice. Drug therapy of chronic venous insufficiency. Fortschr Med 1996;114:196-200. View abstract.

Diehm C, Trampisch HJ, Lange S, Schmidt C. Comparison of leg compression stocking and oral horse-chestnut seed extract in patients with chronic venous insufficiency. Lancet 1996;347:292-4. View abstract.

Diehm C, Vollbrecht D, Amendt K, Comberg HU. Medical edema protection-clinical benefit in patients with chronic deep vein incompetence. Vasa 1992;21:188-92. View abstract.

Bisler H, Pfeifer R, Kluken N, Pauschinger P. [Effects of horse-chestnut seed on transcapillary filtration in chronic venous insufficiency]. Dtsch Med Wochenschr 1986;111:1321-9. View abstract.

Robbers JE, Tyler VE. Tyler's Herbs of Choice: The Therapeutic Use of Phytomedicinals. New York, NY: The Haworth Herbal Press, 1999.

Takegoshi K, Tohyama T, Okuda K, et al. A case of Venoplant-induced hepatic injury. Gastroenterol Jpn 1986;21:62-5. View abstract.

Jaspersen-Schib R, Theus L, Guirguis-Oeschger M, et al. [Serious plant poisonings in Switzerland 1966-1994. Case analysis from the Swiss Toxicology Information Center]. Schweiz Med Wochenschr 1996;126:1085-98. View abstract.

Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm 2000;57:1221-7. View abstract.

Dr. Duke's Phytochemical and Ethnobotanical Databases. Available at: http://www.ars-grin.gov/duke/.

Koch R. Comparative study of venostatin and pycnogenol in chronic venous insufficiency. Phytother Res 2002:16:S1-S5. Phytother Res 2002:16:S1-S5. View abstract.

Popp W, Horak F, Jager S, et al. Horse chestnut (Aesculus hippocastanum) pollen: a frequent cause of allergic sensitization in urban children. Allergy 1992;47:380-3. View abstract.

Blanco C, Diaz-Perales A, Collada C, et al. Class I chitinases as potential panallergens involved in the latex-fruit syndrome. J Allergy Clin Immunol 1999;103:507-13. View abstract.

Schroder H, Clausen N, Ostergard E, Pressler T. Folic acid supplements in vitamin tablets: a determinant of hematological drug tolerance in maintenance therapy of childhood acute lymphoblastic leukemia. Ped Hematol Oncol 1986;3:241-7. View abstract.

Comaish JS, Kersey PJ. Contact dermatitis to extract of horse chestnut (esculin). Contact Dermatitis 1980;6:150-1. View abstract.

Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency (Cochrane Review). In: The Cochrane Library, Issue 3, 2004. Chichester, UK: John Wiley & Sons, Ltd. .

Abebe W. Herbal medication: potential for adverse interactions with analgesic drugs. J Clin Pharm Ther. 2002;27:391-401. View abstract.

Argento A, Tiraferri E, Marzaloni M. [Oral anticoagulants and medicinal plants. An emerging interaction]. Ann Ital Med Int. 2000;15:139-43. View abstract.

Brunner, F., Hoffmann, C., and Schuller-Petrovic, S. Responsiveness of human varicose saphenous veins to vasoactive agents. Br.J Clin Pharmacol. 2001;51(3):219-224. View abstract.

Ottillinger, B. and Greeske, K. Rational therapy of chronic venous insufficiency--chances and limits of the therapeutic use of horse-chestnut seeds extract. BMC.Cardiovasc.Disord. 2001;1(1):5. View abstract.

Pittler, M. H. and Ernst, E. Horse chestnut seed extract for chronic venous insufficiency. Cochrane Database.Syst Rev 2003;(1):CD003230. View abstract.

Siebert, U., Brach, M., Sroczynski, G., and Berla, K. Efficacy, routine effectiveness, and safety of horsechestnut seed extract in the treatment of chronic venous insufficiency. A meta-analysis of randomized controlled trials and large observational studies. Int Angiol. 2002;21(4):305-315. View abstract.

Pittler, M. H. and Ernst, E. Horse chestnut seed extract for chronic venous insufficiency. Cochrane.Database.Syst.Rev. 2004;(2):CD003230. View abstract.

Pittler, M. H. and Ernst, E. Horse chestnut seed extract for chronic venous insufficiency. Cochrane.Database.Syst.Rev 2006;(1):CD003230. View abstract.

Suter, A., Bommer, S., and Rechner, J. Treatment of patients with venous insufficiency with fresh plant horse chestnut seed extract: a review of 5 clinical studies. Adv Ther 2006;23(1):179-190. View abstract.

Xie, Q., Zong, X., Ge, B., Wang, S., Ji, J., Ye, Y., and Pan, L. Pilot postoperative ileus study of escin in cancer patients after colorectal surgery. World J.Surg. 2009;33(2):348-354. View abstract.

Carrasco, O. F., Ranero, A., Hong, E., and Vidrio, H. Endothelial function impairment in chronic venous insufficiency: effect of some cardiovascular protectant agents. Angiology 12-20-2009;60(6):763-771. View abstract.

Fang, Y., Zhao, L., Yan, F., Xia, X., Xu, D., and Cui, X. Escin improves sperm quality in male patients with varicocele-associated infertility. Phytomedicine. 2010;17(3-4):192-196. View abstract.

Snow, A., Halpenny, D., McNeill, G., and Torreggiani, W. C. Life-threatening rupture of a renal angiomyolipoma in a patient taking over-the-counter horse chestnut seed extract. J Emerg.Med 2012;43(6):e401-e403. View abstract.

Luzzi, R., Feragalli, B., Belcaro, G., Cesarone, M. R., Cornelli, U., Dugall, M., and Hosoi, M. Aescin: microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. Panminerva Med. 2011;53(3 Suppl 1):51-55. View abstract.

Wang, G. J. and Liu, J. [Clinical randomized controlled trial on ultrashort wave and magnetic therapy for the treatment of early stage distal radius fractures]. Zhongguo Gu.Shang 2012;25(7):572-575. View abstract.

Pittler, M. H. and Ernst, E. Horse chestnut seed extract for chronic venous insufficiency. Cochrane.Database.Syst.Rev. 2012;11:CD003230. View abstract.

Friederich, H. C., Vogelsberg, H., and Neiss, A. [Evaluation of internally effective venous drugs]. Z.Hautkr. 6-1-1978;53(11):369-374. View abstract.

Horacek, J. [Experience with horse chestnut containing medium in the treatment of varicose leg ulcers]. Z.Haut.Geschlechtskr. 9-15-1969;44(18):743-746. View abstract.

Longiave, D., Omini, C., Nicosia, S., and Berti, F. The mode of action of aescin on isolated veins: relationship with PGF2 alpha. Pharmacol.Res Commun. 1978;10(2):145-152. View abstract.

Williams, M. C. and Olsen, J. D. Toxicity of seeds of three Aesculus spp to chicks and hamsters. Am J Vet.Res 1984;45(3):539-542. View abstract.

Schrader, E., Schwankl, W., Sieder, C., and Christoffel, V. [Comparison of the bioavailability of beta-aescin after single oral administration of two different drug formulations containing an extract of horse-chestnut seeds]. Pharmazie 1995;50(9):623-627. View abstract.

Masaki, H., Sakaki, S., Atsumi, T., and Sakurai, H. Active-oxygen scavenging activity of plant extracts. Biol Pharm Bull. 1995;18(1):162-166. View abstract.

Guillaume, M. and Padioleau, F. Veinotonic effect, vascular protection, antiinflammatory and free radical scavenging properties of horse chestnut extract. Arzneimittelforschung 1994;44(1):25-35. View abstract.

Neiss, A. and Bohm, C. [Demonstration of the effectiveness of the horse-chestnut-seed extract in the varicose syndrome complex]. MMW.Munch.Med Wochenschr 2-13-1976;118(7):213-216. View abstract.

Endl, J. and Auinger, W. [Early detection of postoperative deep-vein thrombosis in gynaecological patients by the 125I-Fibrinogen test (author's transl)]. Wien.Klin.Wochenschr. 4-29-1977;89(9):304-307. View abstract.

Vayssairat, M., Debure, C., Maurel, A., and Gaitz, J. P. Horse-chestnut seed extract for chronic venous insufficiency. Lancet 4-27-1996;347(9009):1182. View abstract.

De Smet, P. A., Van den Eertwegh, A. J., Lesterhuis, W., and Stricker, B. H. Hepatotoxicity associated with herbal tablets. BMJ 7-13-1996;313(7049):92. View abstract.

Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J., Gavaghan, D. J., and McQuay, H. J. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin.Trials 1996;17(1):1-12. View abstract.

Rehn, D., Unkauf, M., Klein, P., Jost, V., and Lucker, P. W. Comparative clinical efficacy and tolerability of oxerutins and horse chestnut extract in patients with chronic venous insufficiency. Arzneimittelforschung 1996;46(5):483-487. View abstract.

Matsuda, H., Li, Y., Murakami, T., Ninomiya, K., Yamahara, J., and Yoshikawa, M. Effects of escins Ia, Ib, IIa, and IIb from horse chestnut, the seeds of Aesculus hippocastanum L., on acute inflammation in animals. Biol Pharm Bull. 1997;20(10):1092-1095. View abstract.

Lange, S., Freitag, G., and Trampisch, H. J. Practical experience with the design and analysis of a three-armed equivalence study. Eur.J Clin Pharmacol. 1998;54(7):535-540. View abstract.

Yoshikawa, M., Murakami, T., Yamahara, J., and Matsuda, H. Bioactive saponins and glycosides. XII. Horse chestnut. (2): Structures of escins IIIb, IV, V, and VI and isoescins Ia, Ib, and V, acylated polyhydroxyoleanene triterpene oligoglycosides, from the seeds of horse chestnut tree (Aesculus hippocastanum L., Hippocastanaceae). Chem Pharm Bull.(Tokyo) 1998;46(11):1764-1769. View abstract.

Grasso A and Covaglia E. Two cases of suspected toxic tubulonephrosis due to escine. Gass Med Ital 1976;135:581-584.

Rudofsky G and et al. Odemprotektive wirkung und klinische wirksamkeit von ro kastaniensamenextrakt im doppeltblindversuch. Phleb Prokto 1986;15(2):47-54.

Kalbfleisch W and Pfalzgraf H. Odemprotektiva: aquipotente dosierung: rokastaniensamenextrakt und O -beta- hydroxyethylrutoside im vergleich. Therapiewoche 1989;39:3703-3707.

Hardin, J. Human Poisoning from Native and Cultivated Plants. Durham, NC: Duke University Press;1974.

Steiner M. Untersuchungen zur odemvermindernden und odemportektiven wirking von ro kastaniensamenextrakt. Phlebol Prokto 1990;19:239-242.

Matsuda H, Yuhao, L, Murakami T, and et al. Antiinflammatory effects of escins Ia, Ib, IIa, and IIb from horse chestnut, the seeds of Aesculus Hippocastanum L. Bioorganic Med Chem Lett 1997;7(13):1611-1616.

Tiffany N, Ulbricht C, Bent S, and et al. Horse chestnut: a multidisciplinary clinical review. Journal of Herbal Pharmacotherapy 2002;2(1):71-85.

Pittler MH and Ernst E. Efficacy of horse chestnut seed extract for chronic venous insufficiency: a systematic review of randomized trials [abstract]. Altern Ther Health Med 2001;7(3):108.

Alter, H. Zur medikamentosen therapie der varikosis. Z Allg Med 1973;49(17):1301-1304.

Erdlen F. Klinische wirksamkeit von Venostasin retard im Doppelblindversuch. Med Welt 1989;40:994-996.

Erler M. Rokastaniensamenextrakt bei der therapie peripherer venoser odeme: ein klinischer therapievergleich. Med Welt 1991;42(7):593-596.

Lohr E, Garanin P, Jesau P, and et al. [Anti-edemic therapy in chronic venous insufficiency with tendency to formation of edema]. Munch.Med Wochenschr 1986;128(34):579-581.

Pilz E. Oedemas in venous disease [Ödeme bei Venenerkrankungen]. Med Welt 1990;41(12):1143-1144.

Cloarec M. Study on the effect of a new vasoprotective Venostasin administered over a period of 2 months in chronic venous insufficiency of the lower limb (data from 1992). Unpublished. 1992;1.

Diehm C, Schmidt C. Venostasin retard gegen Plazebo und Kompression bei Patienten mit CVI II/IIIA. Final Study Report. BMC Cardiovascular Disorders 2001;1:5.

Morales Paris CA and Barros Soares RM. Efficacy and safety on use of dried horse chestnut extract in the treatment of chronic venous insufficiency of the limbs. Revista Brasileira de Medicina 1993;50(11):1563-1565.

Steiner M and Hilemanns HG. Tests for anti-oedema action of a venous therapy [Untersuchung zur oedemprotektiven Wirkung eines Venentherapeutikums]. MMW.Munch.Med Wochenschr 1986;128(31):551-552.

Steiner M and Hillemanns HG. Venostatin retard in the management of venous problems during pregnancy. Phlebology 1990;5(1):41-44.

Simini B. Horse-chestnut seed extract for chronic venous insufficiency. Lancet 1996;337(9009):1182-1183.

Edem E, Kahyaoglu B, Çakar MA. Acute Effusive Pericarditis due to Horse Chestnut Consumption. Am J Case Rep. 2016;17:305-8. View abstract.

Thalmann C, Freise J, Heitland W, Bacher S. Effects of defoliation by horse chestnut leafminer (Cameraria ohridella) on reproduction in Aesculus hippocastanum. Trees. 2003;17:383-8.

Brown K, Scott-Hoy B, Jennings. Efficacy of a Quebracho, Conker Tree, and M. balsamea Willd blended extract in patients with irritable bowel syndrome with constipation. J Gasterenterol Hepatol Res 2015; 4: 1762-1767.

Brown K, Scott-Hoy B, Jennings LW. Response of irritable bowel syndrome with constipation patients administered a combined quebracho/conker tree/M. balsamea Willd extract. World J Gastrointest Pharmacol Ther 2016 August 6; 7(3): 463-468. View abstract.

Ji H, Zhang G, Yue F, Zhou X. Adverse event due to a likely interaction between sodium aescinate and ginkgo biloba extract: a case report. J Clin Pharm Ther. 2017;42(2):237-238. doi: 10.1111/jcpt.12500. View abstract.

Costa Santos D, Lérias G, Madruga I. Drug-induced Liver Injury Due to a Horse Chestnut Dietary Supplement. Eur J Case Rep Intern Med 2021;8(3):002389. View abstract.

Yi HY, Lee JY. Poisoning due to consumption of horse chestnut seed. Clin Exp Emerg Med 2021;8(4):333-335. View abstract.

Al-Azzawi IS. The role of Aescin versus Prednisolone in the management of symptomatic lower ureteral calculi: A comparative study. J Pak Med Assoc 2021;71(Suppl 8)(12):S77-S81. View abstract.